Neoadjuvant TherapyChemotherapy, AdjuvantRadiotherapy, AdjuvantEsophagectomyChemoradiotherapy, AdjuvantBreast NeoplasmsAntineoplastic Combined Chemotherapy ProtocolsAdjuvants, ImmunologicRectal NeoplasmsTreatment OutcomeCombined Modality TherapyNeoplasm StagingEsophageal NeoplasmsFluorouracilAdenocarcinomaDisease-Free SurvivalTaxoidsEpirubicinPrognosisChemoradiotherapyAntineoplastic AgentsDoxorubicinNeoplasm Recurrence, LocalSarcomaFreund's AdjuvantCisplatinSurvival RatePancreatic NeoplasmsReceptor, erbB-2Survival AnalysisAntineoplastic Agents, HormonalRetrospective StudiesCyclophosphamideAntibodies, Monoclonal, HumanizedDeoxycytidinePancreaticoduodenectomyLymphatic MetastasisPancreatectomyNomogramsNeoplasm, ResidualPaclitaxelPositron-Emission TomographyReceptors, EstrogenFluorodeoxyglucose F18Follow-Up StudiesKaplan-Meier EstimateOrganoplatinum CompoundsTumor Markers, BiologicalPredictive Value of TestsProspective StudiesCarcinoma, Squamous CellMastectomy, SegmentalEsophagogastric JunctionPreoperative CareTomography, X-Ray ComputedTumor BurdenLeucovorinAnthracyclinesProstatectomyCarcinoma, Pancreatic DuctalAdjuvants, PharmaceuticRadiopharmaceuticalsSoft Tissue NeoplasmsDrug Administration ScheduleTime FactorsCystectomyCarcinomaNeoplasm MetastasisMultivariate AnalysisImmunohistochemistryReceptors, ProgesteroneCarcinoma, Ductal, BreastAntibodies, MonoclonalBiomarkers, PharmacologicalMuscle NeoplasmsMastectomyNitrilesLung NeoplasmsMethotrexateOsteosarcomaTamoxifenCarcinoma, LobularBridged CompoundsVinblastineLymph Node ExcisionTriazolesKi-67 AntigenUrinary Bladder NeoplasmsAndrogen AntagonistsRisk FactorsAluminum HydroxideAromatase InhibitorsBone NeoplasmsAxillaNeoplasm InvasivenessAntimetabolites, Antineoplastic